S
AXSM icon

SignatureFD’s Axsome Therapeutics AXSM Stock Holding History

SignatureFD’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.2K Buy
246
+17
+7% +$3.69K ﹤0.01% 1757
2026
Q1 		$38.7K Hold
229
– – ﹤0.01% 1877
2025
Q4 		$41.8K Hold
229
– – ﹤0.01% 1754
2025
Q3 		$27.8K Hold
229
– – ﹤0.01% 1952
2025
Q2 		$23.9K Sell
229
-100
-30% -$10.6K ﹤0.01% 1973
2025
Q1 		$38.4K Hold
329
– – ﹤0.01% 1729
2024
Q4 		$27.8K Hold
329
– – ﹤0.01% 1895
2024
Q3 		$29.6K Buy
329
+16
+5% +$1.4K ﹤0.01% 1854
2024
Q2 		$25.2K Hold
313
– – ﹤0.01% 1846
2024
Q1 		$25K Buy
313
+240
+329% +$20.1K ﹤0.01% 1884
2023
Q4 		$5.81K Sell
73
-64
-47% -$4.28K ﹤0.01% 2456
2023
Q3 		$9.57K Buy
137
+64
+88% +$4.78K ﹤0.01% 2231
2023
Q2 		$5.25K Sell
73
-20
-22% -$1.48K ﹤0.01% 2499
2023
Q1 		$5.74K Sell
93
-634
-87% -$41.7K ﹤0.01% 2455
2022
Q4 		$56.1K Buy
727
+627
+627% +$37.5K ﹤0.01% 1302
2022
Q3 		$4K Hold
100
– – ﹤0.01% 2496
2022
Q2 		$4K Sell
100
-27
-21% -$854 ﹤0.01% 2494
2022
Q1 		$5K Sell
127
-451
-78% -$14K ﹤0.01% 2460
2021
Q4 		$22K Buy
578
+320
+124% +$11.8K ﹤0.01% 1736
2021
Q3 		$9K Buy
258
+166
+180% +$6.47K ﹤0.01% 2101
2021
Q2 		$6K Buy
92
+15
+19% +$900 ﹤0.01% 2184
2021
Q1 		$4K Buy
77
+62
+413% +$4.36K ﹤0.01% 2205
2020
Q4 		$1K Buy
15
+2
+15% +$150 ﹤0.01% 2386
2020
Q3 		$1K Buy
+13
New +$1.01K ﹤0.01% 2366

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SignatureFD's AXSM Position: Q2 2026 in Review

SignatureFD increased its Axsome Therapeutics (AXSM) stake by 7.4% in Q2 2026, buying an estimated $3.69K and bringing the position to 246 shares worth $60.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

SignatureFD first reported a position in AXSM in Q3 2020 and has held it in 24 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • SignatureFD held 246 shares of Axsome Therapeutics worth $60.2K as of Q2 2026.
  • SignatureFD bought 17 Axsome Therapeutics shares in Q2 2026, an estimated $3.69K.
  • Axsome Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1757 holding.
  • SignatureFD first reported a position in Axsome Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.